Viz.ai has upgraded its software to include expanded lung disease software capabilities driven by natural language processing and imaging AI.
The expanded capabilities will help clinicians evaluate electronic health record information and triage patients with suspected lung disease for further follow-up, the company said. They will be incorporated into what Viz.ai calls its "AI-powered care acceleration platform."
